News and Events
Upcoming Events
Past Events
Recorded Webinars

Learn how to visualize and quantify any gene, in any species, in any tissue down to the single-cell level with RNAscope® ISH. Request or register for a free seminar presented by RNAscope® expert.

  • Sep
    08
    RNAscope® Seminar Kiel, Germany
    Seminarraum, Biochemie Otto Hahn Platz 9, CAU Kiel
    RNAscope® Seminar Kiel, Germany
    Jacqueline Ay, Ph.D.
    Outline:

    Comprehensive RNA evaluation with RNAscope® and BaseScope™, two highly specific and sensitive in situ hybridization methods.

    • Perform single cell analysis with morphological information in FFPE or frozen tissue
    • Characterize expression profiles of various checkpoint markers and targets in the tumor microenvironment (TME)
    • Evaluate immune function by visualizing mRNA expression of critical molecules including IFNγ and other cytokines and chemokines
    Dates and Registration:
    September
    08
    Register Now
  • Sep
    11
    RNAscope® Technology Seminar - Boston, MA
    RNAscope® Technology Seminar - Boston, MA
    Outline:

    Seminar at Massachusetts General Hospital

    Speakers and Presentations:

    - Combined IHC and RNA ISH to elucidate tumor molecular heterogeneity
    Nallasivam Palanisamy, Ph.D, Associate Scientist/Professor at Henry Ford Health System, Associate Professor (Adjunct) at University of Michigan

    - Current state-of-the-art tissue-based RNA analysis with RNAscope® Technology
    Courtney Anderson, Ph.D, Group Leader Applications, Advanced Cell Diagnostics, Inc. 

    RNAscope® assay is a proprietary RNA in situ hybridization (ISH) assay based on ACD patented signal amplification and background suppression technology which advances RNA biomarker analysis in tissues and cells.
    Using RNAscope® assay you can:

    •    Detect single RNA molecule at single-cell resolution in a single-day
    •    Asses splice variants, highly homologous sequences, lncRNA, and targets lacking IHC antibodies
    •    Analyze tumor heterogeneity using Dual ISH-IHC and Multiplex assays

    This enables researchers to visualize genes that are expressed, localize where they are expressed in any complex tissue from any species. The RNAscope® technology is proven and published in over 900 publications in various research areas such as neuroscience, immuno-oncology, infectious disease and stem cell. This technology is commonly used for dual ISH-IHC analysis, RNA-Seq validation, single-cell analysis, and recently introduce BaseScope™ assay makes detection of exon junctions and highly homologous targets also possible.

    During this session, Dr. Nalla Palanisamy will present his work on prostate cancer and discuss how RNA ISH has been successfully applied to his research. Courtney Anderson will demonstrate how this technology provides unique biological information and has been used in a multitude of research areas - cancer, neuroscience, gene therapy and more. For more information regarding the seminar please click this link: http://rna.acdbio.com/seminars

     

    Dates and Registration:
    September
    11
    Register Now
  • Sep
    12
    RNAscope® Technology Seminar - Buffalo, NY
    Zebro Conference Room
    RNAscope® Technology Seminar - Buffalo, NY
    Sudha Krishnan, Ph.D, Advanced Cell Diagnostics, Inc.
    Visualize gene expression and genetic variations in the tissue environment : RNAscope® and BaseScope™ ISH Assays
    Outline:

    Seminar at Roswell Park Cancer Institute

    RNAscope® assay is a proprietary RNA in situ hybridization (ISH) assay based on ACD patented signal amplification and background suppression technology which advances RNA biomarker analysis in tissues and cells.
    Using RNAscope® assay you can:

    •    Detect single RNA molecule at single-cell resolution in a single-day
    •    Asses splice variants, highly homologous sequences, lncRNA, and targets lacking IHC antibodies
    •    Analyze tumor heterogeneity using Dual ISH-IHC and Multiplex assays

    This enables researchers to visualize genes that are expressed, localize where they are expressed in any complex tissue from any species. The RNAscope® technology is proven and published in over 900 publications in various research areas such as neuroscience, immuno-oncology, infectious disease and stem cell. This technology is commonly used for dual ISH-IHC analysis, RNA-Seq validation, single-cell analysis, and recently introduce BaseScope™ assay makes detection of exon junctions and highly homologous targets also possible.

    Dates and Registration:
    September
    12
    Register Now
  • Sep
    12
    RNAscope® Technology Seminar - Boston, MA
    Outline:

    Seminars at Brigham and Women's Hospital and Harvard Medical School

    Speakers and Presentations:

    - Combined IHC and RNA ISH to elucidate tumor molecular heterogeneity
    Nallasivam Palanisamy, Ph.D, Associate Scientist/Professor at Henry Ford Health System, Associate Professor (Adjunct) at University of Michigan

    - Current state-of-the-art tissue-based RNA analysis with RNAscope® Technology
    Courtney Anderson, Ph.D, Group Leader Applications, Advanced Cell Diagnostics, Inc. 

    RNAscope® assay is a proprietary RNA in situ hybridization (ISH) assay based on ACD patented signal amplification and background suppression technology which advances RNA biomarker analysis in tissues and cells.
    Using RNAscope® assay you can:

    •    Detect single RNA molecule at single-cell resolution in a single-day
    •    Asses splice variants, highly homologous sequences, lncRNA, and targets lacking IHC antibodies
    •    Analyze tumor heterogeneity using Dual ISH-IHC and Multiplex assays

    This enables researchers to visualize genes that are expressed, localize where they are expressed in any complex tissue from any species. The RNAscope® technology is proven and published in over 900 publications in various research areas such as neuroscience, immuno-oncology, infectious disease and stem cell. This technology is commonly used for dual ISH-IHC analysis, RNA-Seq validation, single-cell analysis, and recently introduce BaseScope™ assay makes detection of exon junctions and highly homologous targets also possible.

    During these sessions, Dr. Nalla Palanisamy will present his work on prostate cancer and discuss how RNA ISH has been successfully applied to his research. Courtney Anderson will demonstrate how this technology provides unique biological information and has been used in a multitude of research areas - cancer, neuroscience, gene therapy and more. For more information regarding the seminar please click this link: http://rna.acdbio.com/seminars

    Dates and Registration:
    September
    12
    Register Now
  • Sep
    13
    RNAscope® Technology Seminar - Philadelphia, PA
    Outline:

    Seminars at Univeristy of Pennsylvania and Children's Hospital of Phildadelphia

    Speakers and Presentations:

    - Combined IHC and RNA ISH to elucidate tumor molecular heterogeneity
    Nallasivam Palanisamy, Ph.D, Associate Scientist/Professor at Henry Ford Health System, Associate Professor (Adjunct) at University of Michigan

    - Current state-of-the-art tissue-based RNA analysis with RNAscope® Technology
    Courtney Anderson, Ph.D, Group Leader Applications, Advanced Cell Diagnostics, Inc. 

    RNAscope® assay is a proprietary RNA in situ hybridization (ISH) assay based on ACD patented signal amplification and background suppression technology which advances RNA biomarker analysis in tissues and cells.
    Using RNAscope® assay you can:

    •    Detect single RNA molecule at single-cell resolution in a single-day
    •    Asses splice variants, highly homologous sequences, lncRNA, and targets lacking IHC antibodies
    •    Analyze tumor heterogeneity using Dual ISH-IHC and Multiplex assays

    This enables researchers to visualize genes that are expressed, localize where they are expressed in any complex tissue from any species. The RNAscope® technology is proven and published in over 900 publications in various research areas such as neuroscience, immuno-oncology, infectious disease and stem cell. This technology is commonly used for dual ISH-IHC analysis, RNA-Seq validation, single-cell analysis, and recently introduce BaseScope™ assay makes detection of exon junctions and highly homologous targets also possible.

    During this session, Dr. Nalla Palanisamy will present his work on prostate cancer and discuss how RNA ISH has been successfully applied to his research. Courtney Anderson will demonstrate how this technology provides unique biological information and has been used in a multitude of research areas - cancer, neuroscience, gene therapy and more. For more information regarding the seminar please click this link: http://rna.acdbio.com/seminars

    Dates and Registration:
    September
    13
    Register Now
  • Sep
    14
    RNAscope® Technology Seminar -Ann Arbor, MI
    Outline:

    University of Michigan, Ann Arbor

    Speakers and Presentations:

    - Combined IHC and RNA ISH to elucidate tumor molecular heterogeneity
    Nallasivam Palanisamy, Ph.D, Associate Scientist/Professor at Henry Ford Health System, Associate Professor (Adjunct) at University of Michigan

    - Current state-of-the-art tissue-based RNA analysis with RNAscope® Technology
    Courtney Anderson, Ph.D, Group Leader Applications, Advanced Cell Diagnostics, Inc. 

    RNAscope® assay is a proprietary RNA in situ hybridization (ISH) assay based on ACD patented signal amplification and background suppression technology which advances RNA biomarker analysis in tissues and cells.
    Using RNAscope® assay you can:

    •    Detect single RNA molecule at single-cell resolution in a single-day
    •    Asses splice variants, highly homologous sequences, lncRNA and targets lacking IHC antibodies
    •    Analyze tumor heterogeneity using Dual ISH-IHC and Multiplex assays

    This enables researchers to visualize genes that are expressed, localize where they are expressed in any complex tissue from any species. The RNAscope® technology is proven and published in over 900 publications in various research areas such as neuroscience, immuno-oncology, infectious disease and stem cell. This technology is commonly used for dual ISH-IHC analysis, RNA-Seq validation, single-cell analysis and recently introduce BaseScope™ assay makes detection of exon junctions and highly homologous targets also possible.

    During this session, Dr. Nalla Palanisamy will present his work on prostate cancer and discuss how RNA ISH has been successfully applied to his research. Courtney Anderson will demonstrate how this technology provides unique biological information and has been used in a multitude of research areas - cancer, neuroscience, gene therapy and more. For more information regarding the seminar please click this link: http://rna.acdbio.com/seminars

    Dates and Registration:
    September
    14
    Register Now
Request a custom seminar today:

X
Contact Us

Complete one of the two forms below and we will get back to you.

Advanced Cell Diagnostics

Our new headquarters office starting May 2016:

7707 Gateway Blvd.  
Newark, CA 94560
Toll Free: 1 (877) 576-3636
Phone: (510) 576-8800
Fax: (510) 576-8798

 

Advanced Cell Diagnostics , S.r.l.

Via Calabria15
20090 Segrate (Milano) - Italy

Phone: +39.02.95360323
Fax: +39.02.95360992
For European orders: order_europe@acdbio.com

Advanced Cell Diagnostics China

Building 15, No. 26 Xihuan South Road
Beijing Economic-Technological Development Area
Beijing, China, Zip code: 100176

400-966-1796
info_china@acdbio.com
For general information: Leon Li lli@acdbio.com
Web: www.acdbio.com.cn

For general information: info@acdbio.com
For place an order: order@acdbio.com
For product support: support@acdbio.com
For career opportunities: hr@acdbio.com